Log in to save to my catalogue

Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrin...

Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5400497

Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1

About this item

Full title

Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1

Publisher

England: Oxford University Press

Journal title

Journal of surgical case reports, 2017-04, Vol.2017 (4), p.rjx071

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Thymic epithelial tumors occur in 1–5% of patients with multiple endocrine neoplasia type 1 (MEN 1). Majority of these thymic epithelial tumors are thymic carcinoids and patients with thymoma in MEN 1 is rare. Furthermore, thymoma with neuroendocrine differentiation was also rarely reported. Herein, we report a 68-year-old man having type B3 thymom...

Alternative Titles

Full title

Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5400497

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5400497

Other Identifiers

ISSN

2042-8812

E-ISSN

2042-8812

DOI

10.1093/jscr/rjx071

How to access this item